Annual Revenue
$2.26B$90.98M-3.86%
Summary
- Current Value
- As of today, RPRX annual revenue is $2.26B, down -3.86% on
- Historical Performance
- RPRX annual revenue is down -1.13% over the past 3 years, up +24.77% over the past 5 years
- All-Time High Comparison
- RPRX annual revenue is currently -3.86% below its historical high of $2.35B set on
- 3-Year Low Comparison
- RPRX annual revenue is +1.18% above its 3-year low of $2.24B reached on an earlier date
- Sector Comparison
- RPRX annual revenue is higher than 89.42% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate RPRX annual revenue at $3.21B, +41.95% higher than the current value
- Upcoming Earnings
- As of today, the next annual earnings release for RPRX has not been scheduled
Revenue Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Revenue | $2.26B | -3.9% | -1.1% | +24.8% | +37.0% | |
| Quarterly Revenue | $609.29M | +7.9% | +6.3% | +13.2% | +40.1% | |
| TTM Revenue | $2.35B | +3.7% | +4.6% | +17.1% | +440.4% | |
| Price | $45.19 | +39.2% | +18.9% | -5.8% | – | |
| Annual EPS | $1.91 | -24.5% | +28.0% | -70.2% | +99.6% | |
| PE Ratio | 25.84 | +52.6% | -92.3% | +41.6% | – | |
| Annual Gross Profit | $0.00 | 0.0% | -100.0% | 0.0% | 0.0% | |
| Annual Net Income | $1.33B | -21.7% | +7.2% | -45.9% | +75.4% | |
| Annual EBITDA | $1.29B | -13.4% | -11.1% | -51.2% | +49.9% | |
| $1.29B | -13.4% | -9.7% | -50.7% | +62.7% |
Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.35B | -3.9% | |
| 5Y | $2.35B | -3.9% | |
| All | $2.35B | -3.9% |
Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.24B | N/A | +1.2% |
| 5Y | $2.12B | N/A | +6.7% |
| All | $1.60B | +41.7% |
Revenue Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.79B | $2.35B | -15.64% | |
| $2.70B | $2.26B | -16.32% | |
| $3.21B | N/A | +41.95% | |
| $3.31B | N/A | +46.13% |
🔒 Log In To Unlock Full Data
Revenue History
| Year | Value | Change |
|---|---|---|
| $2.26B | -3.9% | |
| $2.35B | +5.2% | |
| $2.24B | -2.3% | |
| $2.29B | +7.9% | |
| $2.12B | +17.0% |
| Year | Value | Change |
|---|---|---|
| $1.81B | +1.1% | |
| $1.79B | +12.3% | |
| $1.60B | -14.9% | |
| $1.88B | +13.6% | |
| $1.65B | - |
FAQ
What is the current annual revenue of RPRX?
As of today, RPRX annual revenue is $2.26B
What is 1-year change in RPRX annual revenue?
RPRX annual revenue is down -3.86% year-over-year
What is 3-year change in RPRX annual revenue?
RPRX annual revenue is down -1.13% over the past 3 years
How far is RPRX annual revenue from its all-time high?
RPRX annual revenue is currently -3.86% below its historical high of $2.35B set on December 31, 2023
How does RPRX annual revenue rank versus sector peers?
RPRX annual revenue is higher than 89.42% of companies in Healthcare sector
How does the analyst estimate for RPRX annual revenue compare to its current value?
Analysts estimate RPRX annual revenue at $3.21B, +41.95% higher than the current value
When is RPRX next annual earnings release?
As of today, the next annual earnings release for RPRX has not been scheduled
Quarterly Revenue
$609.29M$30.63M+5.29%
Summary
- Current Value
- As of today, RPRX quarterly revenue is $609.29M, up +5.29% on
- Historical Performance
- RPRX quarterly revenue is up +7.90% year-over-year, up +6.25% over the past 3 years
- All-Time High Comparison
- RPRX quarterly revenue is currently -10.92% below its historical high of $683.97M set on
- 3-Year Low Comparison
- RPRX quarterly revenue is +13.61% above its 3-year low of $536.31M reached on
- Sector Comparison
- RPRX quarterly revenue is higher than 88.80% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate RPRX quarterly revenue at $837.77M, +37.50% higher than the current value
- Upcoming Earnings
- As of today, the next earnings release for RPRX has not been scheduled
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Revenue | $609.29M | +5.3% | +7.9% | +6.3% | +13.2% | |
| Annual Revenue | $2.26B | – | -3.9% | -1.1% | +24.8% | |
| TTM Revenue | $2.35B | +1.9% | +3.7% | +4.6% | +17.1% | |
| Price | $45.19 | +13.7% | +39.2% | +18.9% | -5.8% | |
| Quarterly EPS | $0.67 | +838.5% | -45.2% | +104.9% | -15.3% | |
| PE Ratio | 25.84 | +13.7% | +52.6% | -92.3% | +41.6% | |
| Quarterly Gross Profit | $608.01M | +100.0% | +100.0% | +100.0% | +100.0% | |
| Quarterly Net Income | $444.21M | +390.1% | -44.9% | +101.5% | -28.8% | |
| $427.16M | +103.6% | -41.9% | +122.2% | -16.3% | ||
| Quarterly EBITDA | $428.43M | +104.2% | -41.7% | +122.9% | -17.0% |
Quarterly Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $609.29M | at high | |
| 3Y | $683.97M | -10.9% | |
| 5Y | $683.97M | -10.9% | |
| All | $683.97M | -10.9% |
Quarterly Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $568.25M | +7.2% | |
| 3Y | $536.31M | +13.6% | |
| 5Y | $535.96M | +13.7% | |
| All | $434.88M | +40.1% |
Quarterly Revenue Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $693.74M | $578.67M | -16.59% | |
| $763.51M | $609.29M | -20.20% | |
| $837.77M | N/A | +37.50% | |
| $859.00M | N/A | +40.98% |
🔒 Log In To Unlock Full Data
Quarterly Revenue History
FAQ
What is the current quarterly revenue of RPRX?
As of today, RPRX quarterly revenue is $609.29M
What is RPRX quarterly revenue most recent change?
RPRX quarterly revenue was up +5.29% on September 30, 2025
What is 1-year change in RPRX quarterly revenue?
RPRX quarterly revenue is up +7.90% year-over-year
How far is RPRX quarterly revenue from its all-time high?
RPRX quarterly revenue is currently -10.92% below its historical high of $683.97M set on March 31, 2023
How does RPRX quarterly revenue rank versus sector peers?
RPRX quarterly revenue is higher than 88.80% of companies in Healthcare sector
How does the analyst estimate for RPRX quarterly revenue compare to its current value?
Analysts estimate RPRX quarterly revenue at $837.77M, +37.50% higher than the current value
When is RPRX next earnings release?
As of today, the next earnings release for RPRX has not been scheduled
TTM Revenue
$2.35B$44.60M+1.93%
Summary
- Current Value
- As of today, RPRX TTM revenue is $2.35B, up +1.93% on
- Historical Performance
- RPRX TTM revenue is up +3.72% year-over-year, up +4.57% over the past 3 years
- All-Time High Comparison
- RPRX TTM revenue is currently -0.48% below its historical high of $2.36B set on
- 3-Year Low Comparison
- RPRX TTM revenue is +5.04% above its 3-year low of $2.24B reached on an earlier date
- Sector Comparison
- RPRX TTM revenue is higher than 88.89% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate RPRX TTM revenue at $2.59B, +10.37% higher than the current value
- Upcoming Earnings
- As of today, the next earnings release for RPRX has not been scheduled
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Revenue | $2.35B | +1.9% | +3.7% | +4.6% | +17.1% | |
| Annual Revenue | $2.26B | – | -3.9% | -1.1% | +24.8% | |
| Quarterly Revenue | $609.29M | +5.3% | +7.9% | +6.3% | +13.2% | |
| Price | $45.19 | +13.7% | +39.2% | +18.9% | -5.8% | |
| TTM EPS | $1.75 | -23.9% | -31.6% | +50.7% | -71.2% | |
| PE Ratio | 25.84 | +13.7% | +52.6% | -92.3% | +41.6% | |
| TTM Gross Profit | $608.01M | +100.0% | +100.0% | -46.0% | +100.0% | |
| TTM Net Income | $1.30B | -21.8% | -24.0% | +45.6% | -53.2% | |
| TTM EBITDA | $1.53B | -16.7% | -0.7% | +60.7% | -41.8% | |
| $1.53B | -16.7% | -0.8% | +62.5% | -41.4% |
TTM Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.35B | at high | |
| 3Y | $2.36B | -0.5% | |
| 5Y | $2.36B | -0.5% | |
| All | $2.36B | -0.5% |
TTM Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.26B | N/A | +3.8% |
| 3Y | $2.24B | N/A | +5.0% |
| 5Y | $2.12B | N/A | +10.7% |
| All | $434.88M | +440.4% |
TTM Revenue History
FAQ
What is the current TTM revenue of RPRX?
As of today, RPRX TTM revenue is $2.35B
What is RPRX TTM revenue most recent change?
RPRX TTM revenue was up +1.93% on September 30, 2025
What is 1-year change in RPRX TTM revenue?
RPRX TTM revenue is up +3.72% year-over-year
How far is RPRX TTM revenue from its all-time high?
RPRX TTM revenue is currently -0.48% below its historical high of $2.36B set on June 30, 2023
How does RPRX TTM revenue rank versus sector peers?
RPRX TTM revenue is higher than 88.89% of companies in Healthcare sector
How does the analyst estimate for RPRX TTM revenue compare to its current value?
Analysts estimate RPRX TTM revenue at $2.59B, +10.37% higher than the current value
When is RPRX next earnings release?
As of today, the next earnings release for RPRX has not been scheduled
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx